Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (4,541,408)	$ (3,378,285)	$ (7,832,970)
Adjustment to reconcile net loss to net cash (used in) operating activities
Change in derivative liabilities	3,905,199	2,644,916
Interest expense from derivative instruments	152,250	118,905
Employee stock option expense	19,256	17,661	65,744
Depreciation and amortization	62,703	234,458
Provision for doubtful accounts	89,120	0	(58,234)
Changes in operating assets and liabilities
Accounts receivable	(965,132)	(434,297)
Prepaid expenses	12,942	20,360
Other assets	1,494	(514)
Accounts payable and accrued expenses	246,824	(88,177)
Patent settlement liability	(62,287)	(17,841)
Deferred revenue	120,377	311,712
Net cash (used in) operating activities	(958,662)	(571,102)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(45,466)	(18,267)
Net cash (used in) investing activities	(45,466)	(18,267)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from revolving line of credit	300,000	0
Net cash provided by financing activities	300,000	0
Effect of exchange rate changes on cash and cash equivalents	(15,513)	1,222
Net decrease in cash and cash equivalent	(719,641)	(588,147)
Cash and cash equivalents at beginning of period	873,315	1,302,287	1,302,287
Cash and cash equivalents at end of period	153,674	714,140	873,315
Cash paid during the period for:
Income taxes	8,865	0
Interest	176,144	497,510
Promissory Notes Issued for Accrued Interest [Member]
Non-cash transactions
Promissory notes issued for accrued interest	$ 529,000	$ 0